PRURIGO NODULARIS THERAPEUTICS MARKET ANALYSIS

Prurigo Nodularis Therapeutics Market, by Product Type (Corticosteroids, Capsaicin Cream, Antihistamines, Anticonvulsants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Jul 2021
Code : CMI4509
Pages :153
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Prurigo Nodularis Therapeutics Market Restraints

The shortage of skilled healthcare professionals and availability of alternative treatment options are the major factors expected to hinder growth of the global prurigo nodularis therapeutics market. For instance, Pimecrolimus topical agent is as effective as a hydrocortisone treatment and is offered as an alternative topical treatment option that may be implemented in a long-term regimen.

Moreover, phototherapy can be used for the treatment of several inflammatory skin conditions and is also a therapeutic alternative for patients with prurigo nodularis. These factors act as the restraints for the global prurigo nodularis therapeutics market.